Covista Inc. (NYSE:CVSA) is one of the best defensive stocks to buy amid geopolitical tensions. On May 7, Covista Inc. (NYSE:CVSA) raised its revenue and adjusted earnings per share guidance for the year after an impressive third quarter of fiscal 2026.

Romaset/Shutterstock.com

Revenue in the quarter was up 4.5% to $487 million, as total student enrollment increased 6.8% to 100,585, marking the 11th straight quarter of growth. Adjusted net income in the quarter totaled $69 million, or $1.98 a share, a drop from $73.3 million, or $1.92 a share, delivered the same quarter last year.

The solid financial results came as Chamberlain University continued to advance its campus expansion strategy. The university opened six new campuses, with two receiving regulatory approval. Walden University, on its part, expanded student programming heading into the 2026 academic year.

Additionally, Covista raised its full-year revenue guidance from between $1,900 million and $1,940 million to between $1,930 million and $1,945 million, representing 8% to 9% growth. Adjusted earnings per share are expected at between $7.95 and $8.15, representing a 19% to 22% year over year growth.

Covista Inc. (NYSE:CVSA) is America’s largest healthcare educator, operating as the parent company of five accredited academic institutions to address the national healthcare workforce shortage.

While we acknowledge the potential of CVSA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 8 Most Profitable Crypto-Exposed Stocks to Buy Now and 10 Best Robinhood Stocks Under $20 to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.